Evidano is an AI-powered qualitative data analysis platform that ingests surveys and transcripts, supports thematic and coding workflows, and provides transcription, translation, PII redaction, and encrypted storage. Researchers and program teams working on neglected tropical diseases face two problems: abundant survey/text data and few practical tools to produce stage-specific, equity-focused insights. The July 16, 2026 PLOS NTD study (n=2, 652; AS=884, SLF=884, HP=884) shows clear HRQL gaps by disease stage and age. This post explains how to run a reproducible qualitative analysis of HRQL from mixed surveys and transcripts, what the paper’s numbers mean for interventions, and how to operationalize the work in Evidano (www.evidano.com) to produce thematic, frequency, and cross-segment analyses fast.
Key Takeaways
The July 16, 2026 PLOS NTD study in Jiangxi Province found stepwise declines in SF-36 PCS and MCS scores across disease stages, with advanced schistosomiasis (AS) showing the largest deficits. Reproducing and explaining those deficits requires linking SF-36 quantitative scores to coded qualitative themes, prioritizing older adults and low P‑GDP counties for interventions.
- Study scale and design: n=2, 652 participants in a matched 1:1:1 design (AS=884, SLF=884, HP=884) allow stage comparisons.
- Core metrics: median PCS (AS/SLF/HP) = 71.30 / 78.80 / 83.80; median MCS (AS/SLF/HP) = 71.95 / 77.20 / 80.80 (Published July 16, 2026).
- Top correlates: age ≥60 is the strongest negative correlate, plus county-level low P‑GDP and female gender in some models.
- Operational step: map SF-36 domains to themes from transcripts, validate auto-codes with a manual QC sample, and produce executive briefs for policymakers.
Fast take + source
A cross-sectional study published July 16, 2026 in PLOS NTD found stepwise declines in SF-36 scores across disease stages (HP > SLF > AS), with advanced schistosomiasis (AS) showing the lowest physical and mental composite scores.
- Overall sample n=2, 652; matched groups of 884 each (AS, SLF, HP).
- Median PCS/MCS for AS = 71.30 / 71.95, SLF = 78.80 / 77.20, HP = 83.80 / 80.80.
- Source: PLOS NTD (Published: July 16, 2026).
- Top drivers associated with lower HRQL: age ≥60 (77.15% of sample), low regional P‑GDP, and female gender in some models.
Findings snapshot (n=2, 652)
| Date | Metric | Value / detail | Why it matters | Source |
|---|---|---|---|---|
| July 16, 2026 | Sample | n=2, 652 (884 AS, 884 SLF, 884 HP) | Matched 1:1:1 design enables stage comparisons | PLOS NTD |
| July 16, 2026 | Median PCS (AS / SLF / HP) | 71.30 / 78.80 / 83.80 | Physical health declines with disease stage | PLOS NTD |
| July 16, 2026 | Median MCS (AS / SLF / HP) | 71.95 / 77.20 / 80.80 | Mental health also lowest in AS | PLOS NTD |
| July 16, 2026 | Key correlates | Age ≥60 (strongest negative β), low P‑GDP, female | Targets for equity-focused interventions | PLOS NTD |
What the study did (plain English)
The study used a matched cross-sectional survey in Jiangxi Province and the Chinese SF-36 to compare HRQL across advanced schistosomiasis (AS), schistosomiasis-induced liver fibrosis (SLF), and healthy controls (HP).
- Design & measures: The Chinese SF-36 measured eight domains and two composite scores (PCS, MCS), with 884 participants in each stage group.
- Analysis: Nonparametric group tests plus multivariable linear regression (SPSS 27.0) identified correlates including gender, age, county-level P‑DIRH/P‑GDP, geography, and elimination status.
- Limitations: The study is cross-sectional so associations are not causal; county-level socioeconomics can introduce ecological inference issues; exclusion of major comorbidities reduces generalizability.
So what for researchers and program teams: qualitative analysis of HRQL
For health researchers
Stage-stratified thematic coding separates symptoms, stigma, and access narratives and shows AS patients have the largest deficits in physical functioning, vitality, social function, and general health.
Combine quantitative SF-36 scores with open-text responses or interview transcripts to explain why mental composite scores (MCS) and physical composite scores (PCS) diverge across SLF and AS.
For program & policy teams
Prioritize older adults (≥60) and low P‑GDP counties with integrated packages including case management, rehabilitative services, and income support, because the study identifies age and low regional P‑GDP as highest-need strata.
Monitor elimination-status effects with mixed methods: opposing elimination-status associations by stage in the study suggest surveillance and labeling effects that qualitative interviews can unpack.
For UX/monitoring teams
Design surveys and prompts to capture functional limitations and psychosocial drivers such as fatigue, isolation, and care burdens to reveal where interventions should be piloted.
Capture short patient narratives alongside SF-36 to produce quotable evidence for decision-makers and to map themes to PCS/MCS domains.
Do more, faster with Evidano
Problem: mixed inputs (surveys + interviews) are slow to synthesize
Mixed inputs (surveys and interviews) are slow to synthesize without tooling that links quantitative scores to qualitative themes.
Solution: Ingest SF-36 spreadsheets and interview transcripts into Evidano to run parallel thematic and frequency analyses, producing domain-level theme maps aligned to PCS/MCS subscales.
Problem: inconsistent coding across sites
Inconsistent coding across sites reduces comparability of qualitative outputs.
Solution: Upload codebooks and apply Evidano AI-assisted coding to auto-code transcripts, then review and refine codes; export hierarchical codes and subcodes for comparability across counties.
Problem: multilingual field notes, PII concerns
Multilingual field notes and PII concerns complicate centralized analysis.
Solution: Evidano provides transcription with custom dictionaries, translation, and PII redaction so teams can centralize sensitive data securely; data are encrypted and not used to train third-party models. See Evidano for platform details.
Problem: stakeholders want short, evidence-backed recommendations
Stakeholders often need concise, evidence-backed recommendations tied to quantitative metrics.
Solution: Generate clickable quotes, co-occurrence networks, and segment cross-tabs (for example age ≥60 × low P‑GDP) in Evidano to produce a one-page executive brief tied to SF-36 metrics in minutes.
Checklist: 7-step workflow to reproduce these insights
Follow this 7-step checklist to reproduce the SF-36 plus qualitative analysis and produce policy-ready outputs.
Step 1: Import SF-36 spreadsheets and assign group labels (AS/SLF/HP).
Step 2: Upload interview transcripts or open-text survey responses; apply transcription if needed with a custom dictionary.
Step 3: Use Evidano auto-theme extraction to surface the top 10 themes and map themes to SF-36 domains (PF, VT, SF, GH, etc.).
Step 4: Run cross-segment analysis (age groups, P‑GDP high/low, ESS) to get frequency and co-occurrence tables.
Step 5: Validate auto-codes with a 5–10% manual QC sample, refine the codebook, and rerun batch coding.
Step 6: Produce a visualization pack: word cloud, co-occurrence network, hierarchical code tree, and an exportable executive brief.
Step 7: Share a secure report with stakeholders and propose a targeted pilot, for example elder-focused rehabilitation in low P‑GDP counties.
Ethics note
Secure consent and de-identification are required for any work involving patient narratives or PII.
This research context is non-diagnostic and research-focused. For any work involving patient narratives or PII, obtain secure consent and apply de-identification; Evidano supports PII redaction and encrypted storage.
Wrapping up: next moves
Prototype one county dataset using the 7-step workflow to convert SF-36 scores and qualitative narratives into policy-ready recommendations stratified by stage and socioeconomic context.
- Try a secure pilot in Evidano to import your surveys and transcripts, run thematic and cross-segment analyses, and produce visual reports tied to PCS and MCS outcomes.
- For reproducible research, link quantitative SF-36 outputs with coded qualitative themes to explain mechanisms and guide interventions for older adults in low‑GDP counties, the paper’s top priority.
Ready to translate HRQL data into action? Try Evidano for free.
FAQ: AI-enabled qualitative analysis of HRQL
What did the PLOS NTD study find about HRQL by disease stage?
The study found stepwise declines in SF-36 PCS and MCS scores with healthy controls highest, schistosomiasis-induced liver fibrosis (SLF) intermediate, and advanced schistosomiasis (AS) lowest.
Specifically, median PCS (AS/SLF/HP) = 71.30 / 78.80 / 83.80 and median MCS (AS/SLF/HP) = 71.95 / 77.20 / 80.80 in a matched sample of n=2, 652 (884 per group).
How should researchers combine SF-36 scores with qualitative data?
Researchers should map SF-36 domains to coded qualitative themes using stage-stratified thematic coding.
The recommended approach is to extract top themes from transcripts, map themes to PCS/MCS domains, run cross-segment frequency and co-occurrence analyses, and validate auto-coding with manual QC.
Who are the highest-need groups identified in the study?
Older adults age ≥60 and residents of low P‑GDP counties are the highest-need groups identified, with female gender also associated with lower HRQL in some models.
The study reports age ≥60 as the strongest negative correlate and notes county-level socioeconomic status as a key equity target.
What are the study’s main limitations?
The study is cross-sectional, so it reports associations rather than causal relationships.
Additional limitations include the ecological inference risk from county-level socioeconomics and reduced generalizability from excluding major comorbidities.
How can Evidano help with multilingual transcripts and PII?
Evidano provides transcription, translation, and PII redaction capabilities alongside encrypted storage so teams can centralize sensitive data securely.
Use these features to ingest multilingual field notes, apply custom dictionaries, and ensure data protection while running thematic analyses.